Search research articles
Contact Us
Filters
Showing results (11-20 of 89) with videos related to
Page
of 9
Sort By:
Journal of the Neurological Sciences
|
November 6, 1998
Glucocorticosteroid therapy for multiple sclerosis: a critical review
P B Andersson, D E Goodkin
Archives of Neurology
|
March 1, 1990
Screening for cognitive impairment in multiple sclerosis. An evaluation of the Mini-Mental State Examination
W W Beatty, D E Goodkin
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 22, 2001
Secondary leukemia after adjuvant chemotherapy for breast cancer
R G Ghalie, D E Goodkin
The Western Journal of Medicine
|
November 1, 1996
Current pharmacologic treatment of multiple sclerosis symptoms
P B Andersson, D E Goodkin
Bailliere'S Clinical Neurology
|
April 2, 1999
Outcome measures in multiple sclerosis clinical trials
P B Andersson, D E Goodkin
Archives of Physical Medicine and Rehabilitation
|
October 1, 1988
Upper extremity function in multiple sclerosis: improving assessment sensitivity with box-and-block and nine-hole peg tests
D E Goodkin, D Hertsgaard, J Seminary
Archives of Neurology
|
October 1, 1989
Exacerbation rates and adherence to disease type in a prospectively followed-up population with multiple sclerosis. Implications for clinical trials
D E Goodkin, D Hertsgaard, R A Rudick
Archives of Neurology
|
June 1, 1993
The effect of repositioning error on serial magnetic resonance imaging scans
D E Goodkin, S Vanderburg-Medendorp, J Ross
Archives of Neurology
|
July 1, 1992
Biologically significant serum vitamin B12 deficiency in multiple sclerosis inadequately documented
D E Goodkin, D W Jacobsen, R Green
Lancet (London, England)
|
March 1, 1997
How should we proceed with disease-modifying treatments for multiple sclerosis?
P B Andersson, E Waubant, D E Goodkin
Page
of 9
Search research articles
Search
Showing results (11-20 of 89) with videos related to
Sort By:
Page
of 9
Journal of the Neurological Sciences
|
November 6, 1998
Glucocorticosteroid therapy for multiple sclerosis: a critical review
P B Andersson, D E Goodkin
Archives of Neurology
|
March 1, 1990
Screening for cognitive impairment in multiple sclerosis. An evaluation of the Mini-Mental State Examination
W W Beatty, D E Goodkin
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 22, 2001
Secondary leukemia after adjuvant chemotherapy for breast cancer
R G Ghalie, D E Goodkin
The Western Journal of Medicine
|
November 1, 1996
Current pharmacologic treatment of multiple sclerosis symptoms
P B Andersson, D E Goodkin
Bailliere'S Clinical Neurology
|
April 2, 1999
Outcome measures in multiple sclerosis clinical trials
P B Andersson, D E Goodkin
Archives of Physical Medicine and Rehabilitation
|
October 1, 1988
Upper extremity function in multiple sclerosis: improving assessment sensitivity with box-and-block and nine-hole peg tests
D E Goodkin, D Hertsgaard, J Seminary
Archives of Neurology
|
October 1, 1989
Exacerbation rates and adherence to disease type in a prospectively followed-up population with multiple sclerosis. Implications for clinical trials
D E Goodkin, D Hertsgaard, R A Rudick
Archives of Neurology
|
June 1, 1993
The effect of repositioning error on serial magnetic resonance imaging scans
D E Goodkin, S Vanderburg-Medendorp, J Ross
Archives of Neurology
|
July 1, 1992
Biologically significant serum vitamin B12 deficiency in multiple sclerosis inadequately documented
D E Goodkin, D W Jacobsen, R Green
Lancet (London, England)
|
March 1, 1997
How should we proceed with disease-modifying treatments for multiple sclerosis?
P B Andersson, E Waubant, D E Goodkin
Page
of 9